Cochlear Limited
Cochlear Limited CHEOY Peers
See (CHEOY) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CHEOY | $87.08 | +1.74% | 11.39B | 47.58 | $1.83 | +1.61% |
| SMMNY | $27.36 | +1.33% | 122.74B | 27.36 | $1.00 | +0.97% |
| SEMHF | $54.24 | +0.51% | 60.83B | 27.12 | $2.00 | +2.04% |
| RYLPF | $24.83 | -0.01% | 22.97B | 82.76 | $0.30 | +3.85% |
| SONVF | $323.21 | +2.29% | 19.26B | 28.13 | $11.49 | +1.77% |
| SONVY | $63.87 | +1.38% | 19.03B | 27.77 | $2.30 | +1.77% |
| SNNUF | $14.33 | N/A | 12.54B | 30.49 | $0.47 | +2.62% |
| CHEOF | $169.96 | +6.59% | 11.09B | 46.56 | $3.65 | +1.63% |
| WILYY | $18.78 | -14.48% | 8.00B | 18.59 | $1.01 | N/A |
| WILLF | $36.25 | -1.44% | 7.46B | 17.95 | $2.02 | N/A |
Stock Comparison
CHEOY vs SMMNY Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, SMMNY has a market cap of 122.74B. Regarding current trading prices, CHEOY is priced at $87.08, while SMMNY trades at $27.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas SMMNY's P/E ratio is 27.36. In terms of profitability, CHEOY's ROE is +0.20%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, CHEOY is more volatile compared to SMMNY. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs SEMHF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, SEMHF has a market cap of 60.83B. Regarding current trading prices, CHEOY is priced at $87.08, while SEMHF trades at $54.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas SEMHF's P/E ratio is 27.12. In terms of profitability, CHEOY's ROE is +0.20%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, CHEOY is more volatile compared to SEMHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs RYLPF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, RYLPF has a market cap of 22.97B. Regarding current trading prices, CHEOY is priced at $87.08, while RYLPF trades at $24.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas RYLPF's P/E ratio is 82.76. In terms of profitability, CHEOY's ROE is +0.20%, compared to RYLPF's ROE of -0.06%. Regarding short-term risk, CHEOY is less volatile compared to RYLPF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs SONVF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, SONVF has a market cap of 19.26B. Regarding current trading prices, CHEOY is priced at $87.08, while SONVF trades at $323.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas SONVF's P/E ratio is 28.13. In terms of profitability, CHEOY's ROE is +0.20%, compared to SONVF's ROE of +0.26%. Regarding short-term risk, CHEOY is more volatile compared to SONVF. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs SONVY Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, SONVY has a market cap of 19.03B. Regarding current trading prices, CHEOY is priced at $87.08, while SONVY trades at $63.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas SONVY's P/E ratio is 27.77. In terms of profitability, CHEOY's ROE is +0.20%, compared to SONVY's ROE of +0.26%. Regarding short-term risk, CHEOY is more volatile compared to SONVY. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs SNNUF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, SNNUF has a market cap of 12.54B. Regarding current trading prices, CHEOY is priced at $87.08, while SNNUF trades at $14.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas SNNUF's P/E ratio is 30.49. In terms of profitability, CHEOY's ROE is +0.20%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, CHEOY is more volatile compared to SNNUF. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs CHEOF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, CHEOF has a market cap of 11.09B. Regarding current trading prices, CHEOY is priced at $87.08, while CHEOF trades at $169.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas CHEOF's P/E ratio is 46.56. In terms of profitability, CHEOY's ROE is +0.20%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, CHEOY is less volatile compared to CHEOF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs WILYY Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, WILYY has a market cap of 8.00B. Regarding current trading prices, CHEOY is priced at $87.08, while WILYY trades at $18.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas WILYY's P/E ratio is 18.59. In terms of profitability, CHEOY's ROE is +0.20%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, CHEOY is more volatile compared to WILYY. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs WILLF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, WILLF has a market cap of 7.46B. Regarding current trading prices, CHEOY is priced at $87.08, while WILLF trades at $36.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas WILLF's P/E ratio is 17.95. In terms of profitability, CHEOY's ROE is +0.20%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, CHEOY is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs GNGBY Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, GNGBY has a market cap of 5.45B. Regarding current trading prices, CHEOY is priced at $87.08, while GNGBY trades at $19.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas GNGBY's P/E ratio is 35.36. In terms of profitability, CHEOY's ROE is +0.20%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, CHEOY is more volatile compared to GNGBY. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs GNGBF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, GNGBF has a market cap of 5.37B. Regarding current trading prices, CHEOY is priced at $87.08, while GNGBF trades at $21.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas GNGBF's P/E ratio is 37.70. In terms of profitability, CHEOY's ROE is +0.20%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, CHEOY is less volatile compared to GNGBF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs AMBFF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, AMBFF has a market cap of 4.13B. Regarding current trading prices, CHEOY is priced at $87.08, while AMBFF trades at $17.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas AMBFF's P/E ratio is 84.76. In terms of profitability, CHEOY's ROE is +0.20%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, CHEOY is less volatile compared to AMBFF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs AMBBY Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, AMBBY has a market cap of 4.01B. Regarding current trading prices, CHEOY is priced at $87.08, while AMBBY trades at $15.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas AMBBY's P/E ratio is 72.33. In terms of profitability, CHEOY's ROE is +0.20%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, CHEOY is less volatile compared to AMBBY. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs NHNKY Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, NHNKY has a market cap of 3.91B. Regarding current trading prices, CHEOY is priced at $87.08, while NHNKY trades at $11.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas NHNKY's P/E ratio is 16.49. In terms of profitability, CHEOY's ROE is +0.20%, compared to NHNKY's ROE of +0.06%. Regarding short-term risk, CHEOY is less volatile compared to NHNKY. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs NHNKF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, NHNKF has a market cap of 2.48B. Regarding current trading prices, CHEOY is priced at $87.08, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, CHEOY's ROE is +0.20%, compared to NHNKF's ROE of +0.06%. Regarding short-term risk, CHEOY is more volatile compared to NHNKF. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs VTRLY Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, VTRLY has a market cap of 2.22B. Regarding current trading prices, CHEOY is priced at $87.08, while VTRLY trades at $16.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas VTRLY's P/E ratio is 43.13. In terms of profitability, CHEOY's ROE is +0.20%, compared to VTRLY's ROE of +0.04%. Regarding short-term risk, CHEOY is more volatile compared to VTRLY. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs GNNDY Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, GNNDY has a market cap of 2.09B. Regarding current trading prices, CHEOY is priced at $87.08, while GNNDY trades at $43.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas GNNDY's P/E ratio is 17.14. In terms of profitability, CHEOY's ROE is +0.20%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, CHEOY is more volatile compared to GNNDY. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs STSEY Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, STSEY has a market cap of 2.04B. Regarding current trading prices, CHEOY is priced at $87.08, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas STSEY's P/E ratio is 39.41. In terms of profitability, CHEOY's ROE is +0.20%, compared to STSEY's ROE of +0.04%. Regarding short-term risk, CHEOY is more volatile compared to STSEY. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs SSII Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, SSII has a market cap of 1.96B. Regarding current trading prices, CHEOY is priced at $87.08, while SSII trades at $10.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas SSII's P/E ratio is -92.27. In terms of profitability, CHEOY's ROE is +0.20%, compared to SSII's ROE of -1.33%. Regarding short-term risk, CHEOY is less volatile compared to SSII. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs GGNDF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, GGNDF has a market cap of 1.89B. Regarding current trading prices, CHEOY is priced at $87.08, while GGNDF trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas GGNDF's P/E ratio is 15.48. In terms of profitability, CHEOY's ROE is +0.20%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, CHEOY is less volatile compared to GGNDF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs OSSFF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, OSSFF has a market cap of 1.77B. Regarding current trading prices, CHEOY is priced at $87.08, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas OSSFF's P/E ratio is 24.41. In terms of profitability, CHEOY's ROE is +0.20%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, CHEOY is less volatile compared to OSSFF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs DWRKF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, DWRKF has a market cap of 1.75B. Regarding current trading prices, CHEOY is priced at $87.08, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, CHEOY's ROE is +0.20%, compared to DWRKF's ROE of N/A. Regarding short-term risk, CHEOY is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs MCRPF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, MCRPF has a market cap of 1.73B. Regarding current trading prices, CHEOY is priced at $87.08, while MCRPF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas MCRPF's P/E ratio is -7.77. In terms of profitability, CHEOY's ROE is +0.20%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, CHEOY is less volatile compared to MCRPF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs OSSUY Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, OSSUY has a market cap of 1.71B. Regarding current trading prices, CHEOY is priced at $87.08, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, CHEOY's ROE is +0.20%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, CHEOY is more volatile compared to OSSUY. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs MEDGF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, MEDGF has a market cap of 1.67B. Regarding current trading prices, CHEOY is priced at $87.08, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, CHEOY's ROE is +0.20%, compared to MEDGF's ROE of +0.16%. Regarding short-term risk, CHEOY is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs DRWKF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, DRWKF has a market cap of 1.17B. Regarding current trading prices, CHEOY is priced at $87.08, while DRWKF trades at $67.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas DRWKF's P/E ratio is 9.01. In terms of profitability, CHEOY's ROE is +0.20%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, CHEOY is less volatile compared to DRWKF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs XVIPF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, XVIPF has a market cap of 1.04B. Regarding current trading prices, CHEOY is priced at $87.08, while XVIPF trades at $32.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas XVIPF's P/E ratio is 73.11. In terms of profitability, CHEOY's ROE is +0.20%, compared to XVIPF's ROE of +0.07%. Regarding short-term risk, CHEOY is more volatile compared to XVIPF. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs LFTSF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, LFTSF has a market cap of 1.03B. Regarding current trading prices, CHEOY is priced at $87.08, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, CHEOY's ROE is +0.20%, compared to LFTSF's ROE of +0.07%. Regarding short-term risk, CHEOY is more volatile compared to LFTSF. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs DGWPF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, DGWPF has a market cap of 925.04M. Regarding current trading prices, CHEOY is priced at $87.08, while DGWPF trades at $45.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas DGWPF's P/E ratio is 6.88. In terms of profitability, CHEOY's ROE is +0.20%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, CHEOY is less volatile compared to DGWPF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs ELEAF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, ELEAF has a market cap of 832.49M. Regarding current trading prices, CHEOY is priced at $87.08, while ELEAF trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas ELEAF's P/E ratio is 12.08. In terms of profitability, CHEOY's ROE is +0.20%, compared to ELEAF's ROE of +0.14%. Regarding short-term risk, CHEOY is less volatile compared to ELEAF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs MDRSF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, MDRSF has a market cap of 826.63M. Regarding current trading prices, CHEOY is priced at $87.08, while MDRSF trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas MDRSF's P/E ratio is 196.12. In terms of profitability, CHEOY's ROE is +0.20%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, CHEOY is less volatile compared to MDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs CALZF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, CALZF has a market cap of 650.77M. Regarding current trading prices, CHEOY is priced at $87.08, while CALZF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas CALZF's P/E ratio is 94.20. In terms of profitability, CHEOY's ROE is +0.20%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, CHEOY is less volatile compared to CALZF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs AVMR Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, AVMR has a market cap of 494.15M. Regarding current trading prices, CHEOY is priced at $87.08, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas AVMR's P/E ratio is -18.34. In terms of profitability, CHEOY's ROE is +0.20%, compared to AVMR's ROE of -0.24%. Regarding short-term risk, CHEOY is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs CLVSF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, CLVSF has a market cap of 459.85M. Regarding current trading prices, CHEOY is priced at $87.08, while CLVSF trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas CLVSF's P/E ratio is 31.61. In terms of profitability, CHEOY's ROE is +0.20%, compared to CLVSF's ROE of +0.18%. Regarding short-term risk, CHEOY is less volatile compared to CLVSF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs HYBT Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, HYBT has a market cap of 361.36M. Regarding current trading prices, CHEOY is priced at $87.08, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas HYBT's P/E ratio is N/A. In terms of profitability, CHEOY's ROE is +0.20%, compared to HYBT's ROE of -0.02%. Regarding short-term risk, CHEOY is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs IOBCF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, IOBCF has a market cap of 326.64M. Regarding current trading prices, CHEOY is priced at $87.08, while IOBCF trades at $11.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas IOBCF's P/E ratio is 35.97. In terms of profitability, CHEOY's ROE is +0.20%, compared to IOBCF's ROE of +0.08%. Regarding short-term risk, CHEOY is less volatile compared to IOBCF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs EAPIF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, EAPIF has a market cap of 290.45M. Regarding current trading prices, CHEOY is priced at $87.08, while EAPIF trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas EAPIF's P/E ratio is -1.96. In terms of profitability, CHEOY's ROE is +0.20%, compared to EAPIF's ROE of -0.31%. Regarding short-term risk, CHEOY is less volatile compared to EAPIF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs SNWV Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, SNWV has a market cap of 284.32M. Regarding current trading prices, CHEOY is priced at $87.08, while SNWV trades at $33.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas SNWV's P/E ratio is -4.73. In terms of profitability, CHEOY's ROE is +0.20%, compared to SNWV's ROE of +0.78%. Regarding short-term risk, CHEOY is less volatile compared to SNWV. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs CSSPF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, CSSPF has a market cap of 263.38M. Regarding current trading prices, CHEOY is priced at $87.08, while CSSPF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas CSSPF's P/E ratio is 65.00. In terms of profitability, CHEOY's ROE is +0.20%, compared to CSSPF's ROE of +0.16%. Regarding short-term risk, CHEOY is less volatile compared to CSSPF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs CYBQY Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, CYBQY has a market cap of 261.21M. Regarding current trading prices, CHEOY is priced at $87.08, while CYBQY trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas CYBQY's P/E ratio is -40.67. In terms of profitability, CHEOY's ROE is +0.20%, compared to CYBQY's ROE of -0.02%. Regarding short-term risk, CHEOY is less volatile compared to CYBQY. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs CLLKF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, CLLKF has a market cap of 249.36M. Regarding current trading prices, CHEOY is priced at $87.08, while CLLKF trades at $3.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas CLLKF's P/E ratio is -8.02. In terms of profitability, CHEOY's ROE is +0.20%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, CHEOY is more volatile compared to CLLKF. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs HTLZF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, HTLZF has a market cap of 245.15M. Regarding current trading prices, CHEOY is priced at $87.08, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, CHEOY's ROE is +0.20%, compared to HTLZF's ROE of -0.03%. Regarding short-term risk, CHEOY is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs BCCOY Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, BCCOY has a market cap of 221.56M. Regarding current trading prices, CHEOY is priced at $87.08, while BCCOY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas BCCOY's P/E ratio is -7.27. In terms of profitability, CHEOY's ROE is +0.20%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, CHEOY is more volatile compared to BCCOY. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs IMPZY Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, IMPZY has a market cap of 199.95M. Regarding current trading prices, CHEOY is priced at $87.08, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, CHEOY's ROE is +0.20%, compared to IMPZY's ROE of -3.64%. Regarding short-term risk, CHEOY is more volatile compared to IMPZY. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs AVHHL Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, AVHHL has a market cap of 184.25M. Regarding current trading prices, CHEOY is priced at $87.08, while AVHHL trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas AVHHL's P/E ratio is -4.75. In terms of profitability, CHEOY's ROE is +0.20%, compared to AVHHL's ROE of -3.38%. Regarding short-term risk, CHEOY is more volatile compared to AVHHL. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs CYBQF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, CYBQF has a market cap of 173.46M. Regarding current trading prices, CHEOY is priced at $87.08, while CYBQF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas CYBQF's P/E ratio is -43.33. In terms of profitability, CHEOY's ROE is +0.20%, compared to CYBQF's ROE of -0.02%. Regarding short-term risk, CHEOY is more volatile compared to CYBQF. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs EKDHF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, EKDHF has a market cap of 162.48M. Regarding current trading prices, CHEOY is priced at $87.08, while EKDHF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas EKDHF's P/E ratio is 18.00. In terms of profitability, CHEOY's ROE is +0.20%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, CHEOY is less volatile compared to EKDHF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs BRNHF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, BRNHF has a market cap of 161.85M. Regarding current trading prices, CHEOY is priced at $87.08, while BRNHF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, CHEOY's ROE is +0.20%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, CHEOY is less volatile compared to BRNHF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs JMDMF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, JMDMF has a market cap of 154.98M. Regarding current trading prices, CHEOY is priced at $87.08, while JMDMF trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas JMDMF's P/E ratio is -43.25. In terms of profitability, CHEOY's ROE is +0.20%, compared to JMDMF's ROE of N/A. Regarding short-term risk, CHEOY is less volatile compared to JMDMF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs PXMBF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, PXMBF has a market cap of 153.02M. Regarding current trading prices, CHEOY is priced at $87.08, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, CHEOY's ROE is +0.20%, compared to PXMBF's ROE of +0.27%. Regarding short-term risk, CHEOY is more volatile compared to PXMBF. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs BRSYF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, BRSYF has a market cap of 128.39M. Regarding current trading prices, CHEOY is priced at $87.08, while BRSYF trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas BRSYF's P/E ratio is 37.78. In terms of profitability, CHEOY's ROE is +0.20%, compared to BRSYF's ROE of +0.06%. Regarding short-term risk, CHEOY is less volatile compared to BRSYF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs AMEUF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, AMEUF has a market cap of 120.50M. Regarding current trading prices, CHEOY is priced at $87.08, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, CHEOY's ROE is +0.20%, compared to AMEUF's ROE of -6.21%. Regarding short-term risk, CHEOY is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs VMTHF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, VMTHF has a market cap of 110.00M. Regarding current trading prices, CHEOY is priced at $87.08, while VMTHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas VMTHF's P/E ratio is -1.14. In terms of profitability, CHEOY's ROE is +0.20%, compared to VMTHF's ROE of -0.23%. Regarding short-term risk, CHEOY is less volatile compared to VMTHF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs FDMDF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, FDMDF has a market cap of 102.68M. Regarding current trading prices, CHEOY is priced at $87.08, while FDMDF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas FDMDF's P/E ratio is -3.26. In terms of profitability, CHEOY's ROE is +0.20%, compared to FDMDF's ROE of -0.44%. Regarding short-term risk, CHEOY is more volatile compared to FDMDF. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs RSHUF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, RSHUF has a market cap of 91.52M. Regarding current trading prices, CHEOY is priced at $87.08, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, CHEOY's ROE is +0.20%, compared to RSHUF's ROE of -2.32%. Regarding short-term risk, CHEOY is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs CKMTF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, CKMTF has a market cap of 85.19M. Regarding current trading prices, CHEOY is priced at $87.08, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, CHEOY's ROE is +0.20%, compared to CKMTF's ROE of +2.13%. Regarding short-term risk, CHEOY is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs SOMNF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, SOMNF has a market cap of 84.28M. Regarding current trading prices, CHEOY is priced at $87.08, while SOMNF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas SOMNF's P/E ratio is -13.00. In terms of profitability, CHEOY's ROE is +0.20%, compared to SOMNF's ROE of -0.38%. Regarding short-term risk, CHEOY is less volatile compared to SOMNF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs DMTRF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, DMTRF has a market cap of 76.10M. Regarding current trading prices, CHEOY is priced at $87.08, while DMTRF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas DMTRF's P/E ratio is -9.86. In terms of profitability, CHEOY's ROE is +0.20%, compared to DMTRF's ROE of -0.24%. Regarding short-term risk, CHEOY is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs IPDQF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, IPDQF has a market cap of 75.83M. Regarding current trading prices, CHEOY is priced at $87.08, while IPDQF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas IPDQF's P/E ratio is -3.74. In terms of profitability, CHEOY's ROE is +0.20%, compared to IPDQF's ROE of -0.43%. Regarding short-term risk, CHEOY is less volatile compared to IPDQF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs SNZZF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, SNZZF has a market cap of 71.91M. Regarding current trading prices, CHEOY is priced at $87.08, while SNZZF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas SNZZF's P/E ratio is -5.40. In terms of profitability, CHEOY's ROE is +0.20%, compared to SNZZF's ROE of -0.40%. Regarding short-term risk, CHEOY is less volatile compared to SNZZF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs RDGL Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, RDGL has a market cap of 61.00M. Regarding current trading prices, CHEOY is priced at $87.08, while RDGL trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas RDGL's P/E ratio is -13.45. In terms of profitability, CHEOY's ROE is +0.20%, compared to RDGL's ROE of -1.86%. Regarding short-term risk, CHEOY is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs BLOZF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, BLOZF has a market cap of 48.71M. Regarding current trading prices, CHEOY is priced at $87.08, while BLOZF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas BLOZF's P/E ratio is -21.15. In terms of profitability, CHEOY's ROE is +0.20%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, CHEOY is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs NVYTF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, NVYTF has a market cap of 38.00M. Regarding current trading prices, CHEOY is priced at $87.08, while NVYTF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas NVYTF's P/E ratio is -0.78. In terms of profitability, CHEOY's ROE is +0.20%, compared to NVYTF's ROE of -0.23%. Regarding short-term risk, CHEOY is less volatile compared to NVYTF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs TLTFF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, TLTFF has a market cap of 34.69M. Regarding current trading prices, CHEOY is priced at $87.08, while TLTFF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas TLTFF's P/E ratio is -14.00. In terms of profitability, CHEOY's ROE is +0.20%, compared to TLTFF's ROE of -2.17%. Regarding short-term risk, CHEOY is less volatile compared to TLTFF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs ELXMF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, ELXMF has a market cap of 28.41M. Regarding current trading prices, CHEOY is priced at $87.08, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, CHEOY's ROE is +0.20%, compared to ELXMF's ROE of -0.46%. Regarding short-term risk, CHEOY is more volatile compared to ELXMF. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs PYNKF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, PYNKF has a market cap of 24.81M. Regarding current trading prices, CHEOY is priced at $87.08, while PYNKF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas PYNKF's P/E ratio is -1.48. In terms of profitability, CHEOY's ROE is +0.20%, compared to PYNKF's ROE of -1.17%. Regarding short-term risk, CHEOY is less volatile compared to PYNKF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs KBBTF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, KBBTF has a market cap of 24.10M. Regarding current trading prices, CHEOY is priced at $87.08, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, CHEOY's ROE is +0.20%, compared to KBBTF's ROE of N/A. Regarding short-term risk, CHEOY is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs EMITF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, EMITF has a market cap of 22.19M. Regarding current trading prices, CHEOY is priced at $87.08, while EMITF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas EMITF's P/E ratio is -14.29. In terms of profitability, CHEOY's ROE is +0.20%, compared to EMITF's ROE of +0.05%. Regarding short-term risk, CHEOY is less volatile compared to EMITF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs POSC Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, POSC has a market cap of 22.13M. Regarding current trading prices, CHEOY is priced at $87.08, while POSC trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas POSC's P/E ratio is 0.37. In terms of profitability, CHEOY's ROE is +0.20%, compared to POSC's ROE of +9.25%. Regarding short-term risk, CHEOY is less volatile compared to POSC. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs ASAPF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, ASAPF has a market cap of 16.99M. Regarding current trading prices, CHEOY is priced at $87.08, while ASAPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas ASAPF's P/E ratio is -22.00. In terms of profitability, CHEOY's ROE is +0.20%, compared to ASAPF's ROE of -0.20%. Regarding short-term risk, CHEOY is less volatile compared to ASAPF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs RMSL Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, RMSL has a market cap of 16.12M. Regarding current trading prices, CHEOY is priced at $87.08, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas RMSL's P/E ratio is 1.05. In terms of profitability, CHEOY's ROE is +0.20%, compared to RMSL's ROE of -1.94%. Regarding short-term risk, CHEOY is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs VPTDF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, VPTDF has a market cap of 14.57M. Regarding current trading prices, CHEOY is priced at $87.08, while VPTDF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas VPTDF's P/E ratio is -4.47. In terms of profitability, CHEOY's ROE is +0.20%, compared to VPTDF's ROE of +3.89%. Regarding short-term risk, CHEOY is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs TMDIF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, TMDIF has a market cap of 13.91M. Regarding current trading prices, CHEOY is priced at $87.08, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, CHEOY's ROE is +0.20%, compared to TMDIF's ROE of -1.06%. Regarding short-term risk, CHEOY is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs DIZTF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, DIZTF has a market cap of 13.69M. Regarding current trading prices, CHEOY is priced at $87.08, while DIZTF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas DIZTF's P/E ratio is -5.67. In terms of profitability, CHEOY's ROE is +0.20%, compared to DIZTF's ROE of -2.82%. Regarding short-term risk, CHEOY is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs PLLWF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, PLLWF has a market cap of 13.28M. Regarding current trading prices, CHEOY is priced at $87.08, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas PLLWF's P/E ratio is -0.37. In terms of profitability, CHEOY's ROE is +0.20%, compared to PLLWF's ROE of -0.65%. Regarding short-term risk, CHEOY is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs MDXHF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, MDXHF has a market cap of 12.26M. Regarding current trading prices, CHEOY is priced at $87.08, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, CHEOY's ROE is +0.20%, compared to MDXHF's ROE of +0.43%. Regarding short-term risk, CHEOY is more volatile compared to MDXHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs IMEXF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, IMEXF has a market cap of 11.61M. Regarding current trading prices, CHEOY is priced at $87.08, while IMEXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas IMEXF's P/E ratio is N/A. In terms of profitability, CHEOY's ROE is +0.20%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, CHEOY is less volatile compared to IMEXF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs NGMDF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, NGMDF has a market cap of 11.51M. Regarding current trading prices, CHEOY is priced at $87.08, while NGMDF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas NGMDF's P/E ratio is -1.83. In terms of profitability, CHEOY's ROE is +0.20%, compared to NGMDF's ROE of +2.16%. Regarding short-term risk, CHEOY is less volatile compared to NGMDF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs ATBPF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, ATBPF has a market cap of 11.43M. Regarding current trading prices, CHEOY is priced at $87.08, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, CHEOY's ROE is +0.20%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, CHEOY is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs LXXGF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, LXXGF has a market cap of 11.34M. Regarding current trading prices, CHEOY is priced at $87.08, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, CHEOY's ROE is +0.20%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, CHEOY is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs GTHP Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, GTHP has a market cap of 7.80M. Regarding current trading prices, CHEOY is priced at $87.08, while GTHP trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas GTHP's P/E ratio is -2.00. In terms of profitability, CHEOY's ROE is +0.20%, compared to GTHP's ROE of +0.56%. Regarding short-term risk, CHEOY is more volatile compared to GTHP. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs IRME Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, IRME has a market cap of 7.20M. Regarding current trading prices, CHEOY is priced at $87.08, while IRME trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas IRME's P/E ratio is -3.33. In terms of profitability, CHEOY's ROE is +0.20%, compared to IRME's ROE of +506.40%. Regarding short-term risk, CHEOY is less volatile compared to IRME. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs MKEAF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, MKEAF has a market cap of 6.58M. Regarding current trading prices, CHEOY is priced at $87.08, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, CHEOY's ROE is +0.20%, compared to MKEAF's ROE of +0.60%. Regarding short-term risk, CHEOY is more volatile compared to MKEAF. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs DTXMF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, DTXMF has a market cap of 5.69M. Regarding current trading prices, CHEOY is priced at $87.08, while DTXMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas DTXMF's P/E ratio is -0.30. In terms of profitability, CHEOY's ROE is +0.20%, compared to DTXMF's ROE of -0.41%. Regarding short-term risk, CHEOY is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs QLIS Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, QLIS has a market cap of 5.45M. Regarding current trading prices, CHEOY is priced at $87.08, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas QLIS's P/E ratio is 2.22. In terms of profitability, CHEOY's ROE is +0.20%, compared to QLIS's ROE of -8.21%. Regarding short-term risk, CHEOY is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs RHNMF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, RHNMF has a market cap of 5.45M. Regarding current trading prices, CHEOY is priced at $87.08, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, CHEOY's ROE is +0.20%, compared to RHNMF's ROE of -2.48%. Regarding short-term risk, CHEOY is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs VYCO Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, VYCO has a market cap of 4.92M. Regarding current trading prices, CHEOY is priced at $87.08, while VYCO trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas VYCO's P/E ratio is -14.75. In terms of profitability, CHEOY's ROE is +0.20%, compared to VYCO's ROE of +0.03%. Regarding short-term risk, CHEOY is less volatile compared to VYCO. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs MICR Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, MICR has a market cap of 4.73M. Regarding current trading prices, CHEOY is priced at $87.08, while MICR trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas MICR's P/E ratio is -3.47. In terms of profitability, CHEOY's ROE is +0.20%, compared to MICR's ROE of -0.25%. Regarding short-term risk, CHEOY is less volatile compared to MICR. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs ADMT Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, ADMT has a market cap of 4.70M. Regarding current trading prices, CHEOY is priced at $87.08, while ADMT trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas ADMT's P/E ratio is -6.95. In terms of profitability, CHEOY's ROE is +0.20%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, CHEOY is more volatile compared to ADMT. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs TBRIF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, TBRIF has a market cap of 4.54M. Regarding current trading prices, CHEOY is priced at $87.08, while TBRIF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas TBRIF's P/E ratio is -1.00. In terms of profitability, CHEOY's ROE is +0.20%, compared to TBRIF's ROE of -2.22%. Regarding short-term risk, CHEOY is less volatile compared to TBRIF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs FZMD Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, FZMD has a market cap of 4.51M. Regarding current trading prices, CHEOY is priced at $87.08, while FZMD trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas FZMD's P/E ratio is 1.22. In terms of profitability, CHEOY's ROE is +0.20%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, CHEOY is less volatile compared to FZMD. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs NUMD Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, NUMD has a market cap of 4.18M. Regarding current trading prices, CHEOY is priced at $87.08, while NUMD trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas NUMD's P/E ratio is 5.00. In terms of profitability, CHEOY's ROE is +0.20%, compared to NUMD's ROE of +0.35%. Regarding short-term risk, CHEOY is more volatile compared to NUMD. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs LBLTF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, LBLTF has a market cap of 4.07M. Regarding current trading prices, CHEOY is priced at $87.08, while LBLTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas LBLTF's P/E ratio is -0.01. In terms of profitability, CHEOY's ROE is +0.20%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, CHEOY is less volatile compared to LBLTF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs BIEL Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, BIEL has a market cap of 3.62M. Regarding current trading prices, CHEOY is priced at $87.08, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas BIEL's P/E ratio is N/A. In terms of profitability, CHEOY's ROE is +0.20%, compared to BIEL's ROE of +0.04%. Regarding short-term risk, CHEOY is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs VANIW Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, VANIW has a market cap of 3.36M. Regarding current trading prices, CHEOY is priced at $87.08, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas VANIW's P/E ratio is N/A. In terms of profitability, CHEOY's ROE is +0.20%, compared to VANIW's ROE of -1.06%. Regarding short-term risk, CHEOY is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs PMEDF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, PMEDF has a market cap of 2.25M. Regarding current trading prices, CHEOY is priced at $87.08, while PMEDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas PMEDF's P/E ratio is -1.50. In terms of profitability, CHEOY's ROE is +0.20%, compared to PMEDF's ROE of +1.68%. Regarding short-term risk, CHEOY is less volatile compared to PMEDF. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs ALRTF Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, ALRTF has a market cap of 2.22M. Regarding current trading prices, CHEOY is priced at $87.08, while ALRTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas ALRTF's P/E ratio is -0.12. In terms of profitability, CHEOY's ROE is +0.20%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, CHEOY is more volatile compared to ALRTF. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs LLBO Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, LLBO has a market cap of 2.17M. Regarding current trading prices, CHEOY is priced at $87.08, while LLBO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas LLBO's P/E ratio is N/A. In terms of profitability, CHEOY's ROE is +0.20%, compared to LLBO's ROE of +0.00%. Regarding short-term risk, CHEOY is more volatile compared to LLBO. This indicates potentially higher risk in terms of short-term price fluctuations for CHEOY.
CHEOY vs USAQ Comparison
CHEOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHEOY stands at 11.39B. In comparison, USAQ has a market cap of 1.92M. Regarding current trading prices, CHEOY is priced at $87.08, while USAQ trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHEOY currently has a P/E ratio of 47.58, whereas USAQ's P/E ratio is -5.67. In terms of profitability, CHEOY's ROE is +0.20%, compared to USAQ's ROE of +0.61%. Regarding short-term risk, CHEOY is less volatile compared to USAQ. This indicates potentially lower risk in terms of short-term price fluctuations for CHEOY.